A favorite pastime here at BiotechDueDiligence is combing through all those SEC filings that are submitted between 4 PM and 5:30 PM on Friday before a holiday weekend. This time was especially tricky because of the volume of 13-G ownership submissions that came in on the same day. I have included some of the highlights below.
Raises! Bonuses! Stock Options, oh my!
Geron Corp $GERN
Revance Therapeutics $RVNC
Merrimack Pharma $MACK
Generex Biotechnology $GNBT
Selling stock
OWC Pharma $OWCP
Neurometrix $NURO
Cytokinetics $CYTK [more debt]
Headlines
CoCrystal Pharma is your newest CRISPR play $COCP
Threshold Pharma received NASDAQ delisting notice $THLD
Dispute about departure of executive at MusclePharm $MSLP
Biodel receive Paragraph IV notice $BDSI
Provectus extends warrant exchange $PVCT
Incyte files annual report 10-K $INCY [maybe more details about retreat in solid tumors?]
Geron Corp $GERN
Revance Therapeutics $RVNC
Merrimack Pharma $MACK
Generex Biotechnology $GNBT
Selling stock
OWC Pharma $OWCP
Neurometrix $NURO
Cytokinetics $CYTK [more debt]
Headlines
CoCrystal Pharma is your newest CRISPR play $COCP
Threshold Pharma received NASDAQ delisting notice $THLD
Dispute about departure of executive at MusclePharm $MSLP
Biodel receive Paragraph IV notice $BDSI
Provectus extends warrant exchange $PVCT
Incyte files annual report 10-K $INCY [maybe more details about retreat in solid tumors?]
RSS Feed
